Alibaba Health Information Technology Statistics
Want to see HK:0241 full AI Analyst Report?
Alibaba Health Information Technology (0241) Stock Statistics & Valuation Metrics
Total Valuation
Alibaba Health Information Technology has a market cap or net worth of HKD 46.65B. The enterprise value is HKD 63.63B.
- Market Cap
- HKD 46.65B
- Enterprise Value
- HKD 63.63B
Share Statistics
Alibaba Health Information Technology has 16,175,301,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 16,175,301,000
- Owned by Insiders
- ―
- Owned by Institutions
- 7.07%
Financial Efficiency
Alibaba Health Information Technology’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 8.70%.
- Return on Equity (ROE)
- 0.11
- Return on Assets (ROA)
- 0.08
- Return on Invested Capital (ROIC)
- 8.70%
- Return on Capital Employed (ROCE)
- 0.10
- Revenue Per Employee
- 24.57M
- Profits Per Employee
- 1.39M
- Employee Count
- 1,394
- Asset Turnover
- 1.49
- Inventory Turnover
- 14.14
Valuation Ratios
The current PE Ratio of Alibaba Health Information Technology is 19.49. Alibaba Health Information Technology’s PEG ratio is 0.19.
- PE Ratio
- 19.49
- PS Ratio
- 1.10
- PB Ratio
- 2.12
- Price to FCF
- 26.08
- Price to Operating Cash Flow
- 26.11
- PEG Ratio
- 0.19
Income Statement
In the last 12 months, Alibaba Health Information Technology had revenue of 34.26B and earned 1.94B in profits. Earnings per share was 0.12.
- Revenue
- 34.26B
- Gross Profit
- 8.21B
- Operating Income
- 1.84B
- Pretax Income
- 2.27B
- Net Income
- 1.94B
- EBITDA
- 1.47B
- Earnings Per Share (EPS)
- 0.12
Cash Flow
In the last 12 months, operating cash flow was 1.44B and capital expenditures 28,000, giving a free cash flow of 1.44B billion.
- Operating Cash Flow
- 1.44B
- Free Cash Flow
- 1.44B
- Free Cash Flow per Share
- 0.09
Dividends & Yields
Alibaba Health Information Technology pays an annual dividend of HKD 0.22, resulting in a dividend yield of 7.49%
- Dividend Per Share
- HKD 0.22
- Dividend Yield
- 7.49%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 3.84%
- Earnings Yield
- 5.15%
Stock Price Statistics
- Beta
- 1.93
- 52-Week Price Change
- -52.67%
- 50-Day Moving Average
- 2.91
- 200-Day Moving Average
- 3.67
- Relative Strength Index (RSI)
- 46.46
- Average Volume (3m)
- 67.08M
Important Dates
Alibaba Health Information Technology upcoming earnings date is Nov 24, 2026, TBA (Not Confirmed).
- Last Earnings Date
- May 14, 2026
- Next Earnings Date
- Nov 24, 2026
- Ex-Dividend Date
- Aug 12, 2026
Financial Position
Alibaba Health Information Technology as a current ratio of 3.03, with Debt / Equity ratio of 0.33%
- Current Ratio
- 3.03
- Quick Ratio
- 2.66
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -3.87
- Interest Coverage Ratio
- 1357.38
Taxes
In the past 12 months, Alibaba Health Information Technology has paid 337.88M in taxes.
- Income Tax
- 337.88M
- Effective Tax Rate
- 0.15
Enterprise Valuation
Alibaba Health Information Technology EV to EBITDA ratio is 21.75, with an EV/FCF ratio of 22.12.
- EV to Sales
- 0.93
- EV to EBITDA
- 21.75
- EV to Free Cash Flow
- 22.12
- EV to Operating Cash Flow
- 22.12
Balance Sheet
Alibaba Health Information Technology has HKD 10.45B in cash and marketable securities with HKD 59.56M in debt, giving a net cash position of HKD 10.39B billion.
- Cash & Marketable Securities
- HKD 10.45B
- Total Debt
- HKD 59.56M
- Net Cash
- HKD 10.39B
- Net Cash Per Share
- HKD 0.64
- Tangible Book Value Per Share
- HKD 1.03
Margins
Gross margin is 23.97%, with operating margin of 5.36%, and net profit margin of 5.65%.
- Gross Margin
- 23.97%
- Operating Margin
- 5.36%
- Pretax Margin
- 6.64%
- Net Profit Margin
- 5.65%
- EBITDA Margin
- 4.28%
- EBIT Margin
- 4.13%
Analyst Forecast
The average price target for Alibaba Health Information Technology is HKD 4.21, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- HKD 4.21
- Price Target Upside
- 53.93% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 4
- Revenue Growth Forecast
- 14.03%
- EPS Growth Forecast
- 36.55%
Scores
- Smart Score
- 5
- AI Score
- 64

